Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10560629rdf:typepubmed:Citationlld:pubmed
pubmed-article:10560629lifeskim:mentionsumls-concept:C1457887lld:lifeskim
pubmed-article:10560629lifeskim:mentionsumls-concept:C0002736lld:lifeskim
pubmed-article:10560629lifeskim:mentionsumls-concept:C0001554lld:lifeskim
pubmed-article:10560629lifeskim:mentionsumls-concept:C1273870lld:lifeskim
pubmed-article:10560629lifeskim:mentionsumls-concept:C2698651lld:lifeskim
pubmed-article:10560629pubmed:issue8 Suppl 5lld:pubmed
pubmed-article:10560629pubmed:dateCreated1999-11-19lld:pubmed
pubmed-article:10560629pubmed:abstractTextThe advances in treatment for amyotrophic lateral sclerosis (ALS) have demonstrated the need to diagnose this disease precisely and directly. Two international initiatives, at El Escorial in 1990 and at Airlie House in 1998, have grappled with the clinical and laboratory elements that may accelerate the diagnostic process. Shortly after the Airlie House meeting in 1998, an international group of clinical neurologists met to discuss optimal management strategies in ALS. The goals were to examine current diagnosis and treatment pathways and to attempt to devise an algorithm that would foster early diagnosis, thus enhancing the possibility of optimal treatment.lld:pubmed
pubmed-article:10560629pubmed:languageenglld:pubmed
pubmed-article:10560629pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10560629pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10560629pubmed:statusMEDLINElld:pubmed
pubmed-article:10560629pubmed:issn0028-3878lld:pubmed
pubmed-article:10560629pubmed:authorpubmed-author:BrooksB RBRlld:pubmed
pubmed-article:10560629pubmed:issnTypePrintlld:pubmed
pubmed-article:10560629pubmed:volume53lld:pubmed
pubmed-article:10560629pubmed:ownerNLMlld:pubmed
pubmed-article:10560629pubmed:authorsCompleteYlld:pubmed
pubmed-article:10560629pubmed:paginationS1-3; discussion S20-1lld:pubmed
pubmed-article:10560629pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:10560629pubmed:meshHeadingpubmed-meshheading:10560629...lld:pubmed
pubmed-article:10560629pubmed:meshHeadingpubmed-meshheading:10560629...lld:pubmed
pubmed-article:10560629pubmed:meshHeadingpubmed-meshheading:10560629...lld:pubmed
pubmed-article:10560629pubmed:meshHeadingpubmed-meshheading:10560629...lld:pubmed
pubmed-article:10560629pubmed:meshHeadingpubmed-meshheading:10560629...lld:pubmed
pubmed-article:10560629pubmed:year1999lld:pubmed
pubmed-article:10560629pubmed:articleTitleDefining optimal management in ALS: from first symptoms to announcement.lld:pubmed
pubmed-article:10560629pubmed:affiliationALS Clinical Research Center, University of Wisconsin-Madison, and William S. Middleton Memorial VA Medical Center, 53792-5132, USA. Brooks@neurology.wisc.edulld:pubmed
pubmed-article:10560629pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10560629pubmed:publicationTypeReviewlld:pubmed
pubmed-article:10560629pubmed:publicationTypeConsensus Development Conferencelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10560629lld:pubmed